CONCURRENT TARGETING OF ONCOGENIC PATHWAYS TO ENHANCE CHEMOTHERAPY AND IMMUNOTHERAPY
The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subje...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
02.02.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to the field of cancer. More specifically, the present invention provides compositions and methods for treating cancer by targeting YAP1 and STAT3 pathways. In a specific embodiment, the present invention provides a method for increasing sensitivity of cancer in a subject to chemotherapy and/or immunotherapy comprising the step of administering to the subject an effective amount of a YAP1 inhibitor and a STAT3 inhibitor.
La présente invention concerne le domaine du cancer. Plus spécifiquement, la présente invention concerne des compositions et des méthodes de traitement du cancer par ciblage des voies YAP1 et STAT3. Dans un mode de réalisation spécifique, la présente invention concerne une méthode pour augmenter la sensibilité d'un cancer chez un sujet à une chimiothérapie et/ou une immunothérapie, comprenant l'étape consistant à administrer au sujet une quantité efficace d'un inhibiteur de YAP1 et d'un inhibiteur de STAT3. |
---|---|
Bibliography: | Application Number: WO2022US74397 |